Alcoholic liver disease echocardiography or ultrasound

Jump to navigation Jump to search

Alcoholic liver disease Microchapters


Patient Information


Historical Perspective




Differentiating Alcoholic liver disease from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings


X Ray



Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Alcoholic liver disease echocardiography or ultrasound On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Alcoholic liver disease echocardiography or ultrasound

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Alcoholic liver disease echocardiography or ultrasound

CDC on Alcoholic liver disease echocardiography or ultrasound

Alcoholic liver disease echocardiography or ultrasound in the news

Blogs on Alcoholic liver disease echocardiography or ultrasound

Directions to Hospitals Treating Alcoholic liver disease

Risk calculators and risk factors for Alcoholic liver disease echocardiography or ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]


Echocardiography/ultrasound may be helpful in the diagnosis of alcoholic liver disease. Since ultrasound is a non invasive technique it is used for initial evaluation of the liver. Findings on an ultrasound are suggestive of underlying liver disease but they can not confirm the etiology. However ultrasound can be used to exclude other causes of abnormal liver tests in patients who abuse alcohol; infiltrative disease, neoplastic disease, obstructive biliary pathology, cirrhosis or screen for hepatocellular carcinoma. Echocardiography can be used to detect hepatic cardiomyopathy and the severity of volume overload in cirrhotic patients.



  1. Vilgrain V (2001). "Ultrasound of diffuse liver disease and portal hypertension". Eur Radiol. 11 (9): 1563–77. doi:10.1007/s003300101050. PMID 11511876.
  2. Valls C, Iannacconne R, Alba E, Murakami T, Hori M, Passariello R, Vilgrain V (2006). "Fat in the liver: diagnosis and characterization". Eur Radiol. 16 (10): 2292–308. doi:10.1007/s00330-006-0146-0. PMID 16477402.
  3. Palmentieri B, de Sio I, La Mura V, Masarone M, Vecchione R, Bruno S, Torella R, Persico M (2006). "The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis". Dig Liver Dis. 38 (7): 485–9. doi:10.1016/j.dld.2006.03.021. PMID 16716779.
  4. Saverymuttu SH, Joseph AE, Maxwell JD (1986). "Ultrasound scanning in the detection of hepatic fibrosis and steatosis". Br Med J (Clin Res Ed). 292 (6512): 13–5. PMC 1338970. PMID 3080046.
  5. Moaref A, Zamirian M, Yazdani M, Salehi O, Sayadi M, Aghasadeghi K (2014). "The Correlation between Echocardiographic Findings and QT Interval in Cirrhotic Patients". Int Cardiovasc Res J. 8 (2): 39–43. PMC 4058482. PMID 24936479.

​​ Template:WS Template:WH